AAIC 2025 Abstract
Slow wave sleep as a biomarker and therapeutic target for Alzheimer's disease
Experiments in animalsInterventions
Abstract
Background: Sleep disturbances are prevalent among individuals diagnosed with Alzheimer's disease (AD), typically manifested as low levels of slow‐wave sleep (SWS; N3 stage). Restoring SWS has been proposed as an intervention to slow AD progression.
